ImmuCell Stock
ImmuCell Corporation
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- F. Olivier Te Boekhorst
- Employees
- 73
- Market cap
- $98 M
- IPO
- 05/05/1987
- Web
- immucell.com
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense,…
ImmuCell stock: price history
1D
+1.8%
1W
+9.7%
1M
+11.9%
6M
+34.7%
YTD
+74.8%
1Y
+72.0%
2Y
+202.0%
5Y
+15.8%
10Y
+61.7%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~24% weaker price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about ImmuCell
ImmuCell stock metrics
P/E
127.07
P/B
3.11
EV/EBITDA
28.62
RETURN ON EQUITY
5.8%
NET MARGIN
25.5%
DEBT/EQUITY
0.4
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
66.4%
FLOAT SHARES
6,032,214
AVG. DAILY VOLUME (30D)
12,821
Insider transactions (SEC)
te Boekhorst Paul Francis Olivier
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about ImmuCell stock
What does ImmuCell do?
ImmuCell Corporation is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is F. Olivier Te Boekhorst, the company employs around 73 people.
The IPO was on 05/05/1987; the stock trades on NASDAQ under the ticker ICCC.
When does ImmuCell report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly -24% stronger than usual.
Does ImmuCell pay a dividend?
No, ImmuCell currently does not pay a dividend.
Which stocks are comparable to ImmuCell?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get ImmuCell stock analyzed?
Clicking "Analyze stock" lets five strategies assess ImmuCell against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.